Caplin Point Laboratories shares jumped almost 10 percent in trade on September 5 to a fresh lifetime high, extending its gains. Over the past one month, Caplin Point Labs shares have jumped almost 40 percent.
So far in the day, around 14 lakh shares of the company changed hands on BSE and NSE combined, compared to the one-week average of three lakh equity shares.
At 10.25 am, Caplin Point Lab's stock price was quoting Rs 1,248 on the NSE, higher by 9.5 percent as against the previous session's closing price.
Follow our market blog to catch all the live updates
On August 18, the Brazilian Health Regulatory Agency concluded its inspection on Caplin Point Labs' unit. The regulatory agency or ANVISA conducted an inspection of Caplin Steriles’ injectable and ophthalmic manufacturing facility located at Gummidipoondi. The inspection was conducted between August 12 and 16, 2024 and was concluded with zero observations.
The firm's chairman C C Paarthipan said, “It is indeed gratifying to have two back to back audits with zero observations. We remain steadfast in our commitment to maintaining the highest levels of quality compliance at all our sites."
Brazil is an important part of our expansion plans in Latin America and this clearance opens the door to the largest market in that geography, he added.
Over the past 12 months, Caplin Point Laboratories shares have jumped over 90 percent, outperforming the frontline Nifty 50 index that has gained around 50 percent in trade during the same time period.
Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
